Comparison of Adhesive Latch Device to Subcuticular Skin Closure at the Time of Cesarean Section

February 13, 2017 updated by: Robert J. Rubino, MD, FACOG, Rubino Ob-Gyn Group
The objective of this study was to compare the an adhesive latch device (" Dermaclip") to subcuticular skin closure at the time of cesarean section. Currently, no studies exist comparing these two closure techniques. The hypothesis is dermaclip closure is faster than subcuticular closure. The null hypothesis is there is no difference in closure times. There is a study (see reference at bottom) that compares staples closure to subcuticular closure, but none comparing subcuticular to dermaclip closure. Dermaclip device is easily deployed and is expected to be as fast as staples closure compared to subcuticular as noted in the prior study referenced below.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • West Orange, New Jersey, United States, 07052
        • Recruiting
        • Rubino OBGYN Group
        • Contact:
        • Contact:
        • Principal Investigator:
          • Robert J Rubino, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Age greater than 18
  2. Elective cesarean section
  3. Term pregnancy

Exclusion Criteria:

  1. Fever >101F in the past 14 days
  2. Antibiotics in the past 14 days
  3. Suspected ongoing infection
  4. Poorly controlled gestational diabetes
  5. Allergic to adhesive

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Subcuticular arm
closure technique that the Adhesive Latch arem (dermaclip) arm is being compared to
subcuticular suture will be used as the device to close the skin in this arm
Other Names:
  • sucuticular
Active Comparator: Adhesive Latch Arm (Demaclip arm)
This is the arm which the adhesive latch system is used and it is being compared to the arm of subcuticular
Dermaclip is an adhesive latch device used for skin closure
Other Names:
  • adhesive latch device, dermaclip

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of adhesive latch device to subcuticular skin closure at the time of cesarean section
Time Frame: 18 months
The time for skin closure between subcuticular and demaclip techniques will compared during cesarean section
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Scores
Time Frame: 18 months
- pain scores using the visual analog pain scale (VAPS) system
18 months
Wound Infections as measured in centimeters of erythema
Time Frame: 18 months
- wound infections will measured in centimeters of redness/erythema around the infected area
18 months
Wound separation as measured in centimeters
Time Frame: 18 months
- wound separation will be recorded centimeters
18 months
Patient Satisfaction scores
Time Frame: 18 months
- patient satisfaction
18 months
Total surgery time
Time Frame: 18 months
- total surgery time
18 months
Age
Time Frame: 18 months
- age (years)
18 months
BMI
Time Frame: 18 months
BMI of participants bmi (in kg/m2, weight in kg, height, in meters)
18 months
Ethnicity
Time Frame: 18 months
Ethnic origin
18 months
Race
Time Frame: 18 months
Race of participants
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Anticipated)

November 30, 2017

Study Completion (Anticipated)

March 1, 2018

Study Registration Dates

First Submitted

February 3, 2017

First Submitted That Met QC Criteria

February 9, 2017

First Posted (Actual)

February 14, 2017

Study Record Updates

Last Update Posted (Actual)

February 15, 2017

Last Update Submitted That Met QC Criteria

February 13, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Rubinoobgyn

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wound

Clinical Trials on Subcuticular suture

Subscribe